Genotype 1, previously treated with NS5A inhibitor, not previously treated with NS3/4a protease inhibitor, compensated cirrhotic/non-cirrhotic: 16 weeks
Genotype 1, previously treated with NS3/4a protease inhibitor, not previously treated with NS5A inhibitor, compensated cirrhotic/non-cirrhotic: 12 weeks
Genotype 1, 2, 4-6, previously treated with interferon, ribavirin, or sofosbuvir, no previous experience with NS5A or NS3/4A inhibitor, non-cirrhotic: 8 weeks
Genotype 1, 2, 4-6, previously treated with interferon, ribavirin, or sofosbuvir, no previous experience with NS5A or NS3/4A inhibitor, compensated cirrhotic: 12 weeks
Genotype 3, previously treated with interferon, ribavirin, or sofosbuvir, no previous experience with NS5A or NS3/4A inhibitor, compensated cirrhotic/non-cirrhotic: 16 weeks